People News

Share this article:

Avila Therapeutics, a biopharma focused on viral infection, cancer and autoimmune diseases, appointed Katrine Bosley to CEO. Bosley was previously VP, strategic operations at Adnexus, acquired by Bristol-Myers Squibb in 2007. Prior to Adnexus, Bosley worked in various capacities – including business development, commercial operations and portfolio strategy – at Biogen Idec.

 

New York City-based Keryx Biopharmaceuticals announced the appointment of Ron Bentsur to CEO. Bensur was most recently CEO at XTL Biopharmaceuticals.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Channel

 

Did you miss January's Top 40 Healthcare Transformers issue? Read how these inventors, strategists, entrepreneurs and wonks are challenging, disrupting and otherwise transforming the healthcare business. And join us April 30 to honor them at the Transforming Healthcare Dinner. Click here.